FDA product code · Clinical chemistry

Plasma Viscometer For Clinical Use

Name: FDA decisions, review times, recalls and adverse event reports for product code JJL
Creator: 510(k) Report

JJLClass I21 CFR 862.2920510(k) exempt1 decision since 19880 recalls

FDA lists JJL as exempt from 510(k): a device of this type needs no clearance unless one of the limits in 21 CFR 862.9 applies, such as a new intended use or a different fundamental technology. 1 FDA decision since 1988. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, clinical chemistry panel

Twenty years of JJL at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · JJL

FDA has decided no JJL device since 2007.

Median 510(k) review, days · JJL

Too few JJL 510(k)s in any year since 2007 to give a median.

Recalls per year · JJL

No recall names JJL since 2007.

Adverse event reports per year · JJL

No MAUDE report names JJL since 2007.

View these four charts as a table

Year	Median 510(k) review, days	MAUDE reports
2007	—	0
2008	—	0
2009	—	0
2010	—	0
2011	—	0
2012	—	0
2013	—	0
2014	—	0
2015	—	0
2016	—	0
2017	—	0
2018	—	0
2019	—	0
2020	—	0
2021	—	0
2022	—	0
2023	—	0
2024	—	0
2025	—	0
2026	—	—

FIG. 1 — JJL by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in JJL? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Plasma Viscometer For Clinical Use

What has FDA decided in JJL lately?